Skip to main content
Premium Trial:

Request an Annual Quote

Biogenes Technologies Raises $5.7M in Series A Round

NEW YORK — Biogenes Technologies, a Malaysian provider of genomic and molecular research products, said earlier this month that it has raised $5.7 million in Series A funding.

The money was provided by venture capital firm Pembangunan Ekuiti.

Founded in 2015, Biogenes designs and supplies a range of products for healthcare, ag-bio, food safety, and environmental testing applications including diagnostic biosensors, DNA immobilization probes, and aptamers.

The company said it will use the newly raised money to expand its commercial footprint in Southeast Asia and elsewhere.

"Biogenes will invest in a medical-grade manufacturing facility, advancing our technology portfolio, and expanding our sales outreach to the Southeast Asia region and other parts of the world," Biogenes Cofounder and CEO Tang Kok Mun said in a statement. "We [aim] to have the capacity to produce 10 million test kits [for aptamer-based diagnostics] per year."

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.